| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 15,214.48 | 11,999.94 | 10,101.85 | 9,189.13 |
| Accumulated Depreciation Total | -1,556.41 | -947.87 | -735.73 | -607.04 |
| Cash Equivalents | 561.25 | 933.05 | 1,340.79 | 440.70 |
| Other Liabilities Total | 604.04 | 639.77 | 605.10 | 668.40 |
| Long Term Debt | 2,268.51 | 1,058.26 | 492.88 | 624.60 |
| Common Stock Total | 972.14 | 971.91 | 970.92 | 969.61 |
| Other Equity Total | -6.05 | -1.50 | 4.95 | - |
| Other Current Assets Total | 20.42 | 119.43 | 93.39 | 18.34 |
| Prepaid Expenses | 28.51 | 13.11 | 10.60 | 15.01 |
| Total Assets | 15,214.48 | 11,999.94 | 10,101.85 | 9,189.13 |
| Current Portof LT Debt/ Capital Leases | 179.09 | 49.19 | 16.26 | 113.80 |
| Additional Paid- In Capital | 5,184.15 | 5,181.75 | 5,158.03 | 5,143.13 |
| Cash | 100.33 | 46.79 | 33.89 | 40.27 |
| Total Equity | 9,380.87 | 8,408.14 | 7,409.59 | 6,282.47 |
| Long Term Investments | 7.55 | 65.15 | 0.51 | 0.51 |
| Retained Earnings( Accumulated Deficit) | 3,230.63 | 2,255.98 | 1,275.69 | 169.73 |
| Total Common Shares Outstanding | 97.21 | 97.19 | 97.09 | 96.96 |
| Property/ Plant/ Equipment Total- Gross | 7,918.79 | 4,638.95 | 2,961.36 | 2,665.35 |
| Tangible Book Valueper Share Common Eq | 34.41 | 29.07 | 24.14 | 12.09 |
| Goodwill Net | 3,480.26 | 2,952.47 | 2,454.66 | 2,454.66 |
| Total Liabilities | 5,833.61 | 3,591.80 | 2,692.26 | 2,906.66 |
| Total Debt | 3,010.29 | 1,298.95 | 688.96 | 913.38 |
| Cashand Short Term Investments | 661.58 | 979.84 | 1,374.68 | 511.07 |
| Total Receivables Net | 775.85 | 513.96 | 388.17 | 394.51 |
| Notes Payable/ Short Term Debt | 63.59 | 61.29 | 68.24 | 0.00 |
| Deferred Income Tax | 648.19 | 514.85 | 437.13 | 681.41 |
| Accounts Receivable- Trade Net | 735.90 | 498.81 | 366.66 | 385.36 |
| Property/ Plant/ Equipment Total- Net | 6,362.38 | 3,691.08 | 2,225.63 | 2,058.31 |
| Total Current Liabilities | 1,813.77 | 1,248.71 | 1,045.57 | 757.27 |
| Total Inventory | 106.21 | 79.84 | 76.23 | 61.36 |
| Accounts Payable | 807.92 | 677.47 | 543.46 | 452.08 |
| Other Currentliabilities Total | 763.17 | 460.76 | 417.61 | 191.39 |
| Total Long Term Debt | 2,767.61 | 1,188.47 | 604.46 | 799.58 |
| Intangibles Net | 2,555.01 | 2,630.15 | 2,610.84 | 2,655.73 |
| Other Long Term Assets Total | 380.64 | 362.53 | 314.10 | 462.71 |
| Note Receivable- Long Term | 836.07 | 592.38 | 553.04 | 556.92 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,592.57 | 1,706.18 | 1,943.07 | 1,000.29 |
| Capital Lease Obligations | 499.10 | 130.21 | 111.58 | 174.98 |
| Short Term Investments | - | - | - | 30.10 |
Max Healthcare Institute Dividend Max Healthcare Institute Bonus Max Healthcare Institute News Max Healthcare Institute AGM Max Healthcare Institute Rights Max Healthcare Institute Splits Max Healthcare Institute Board Meetings Max Healthcare Institute Key Metrics Max Healthcare Institute Shareholdings Max Healthcare Institute Profit Loss Max Healthcare Institute Cashflow Max Healthcare Institute Q1 Results Max Healthcare Institute Q2 Results Max Healthcare Institute Q3 Results Max Healthcare Institute Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.